<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889201/" ref="ordinalpos=391&amp;ncbi_uid=5701883&amp;link_uid=PMC3889201" image-link="/pmc/articles/PMC3889201/figure/F4/" class="imagepopup">Figure 4.  From: The Human Sulfatase 2 Inhibitor 2,4-Disulfonylphenyl-tert-Butylnitrone (OKN-007) has an Antitumor Effect in Hepatocellular Carcinoma Mediated via Suppression of TGFB1/SMAD2 and Hedgehog/GLI1 <span class="highlight" style="background-color:">Signaling</span>. </a></div><br /><div class="p4l_captionBody">OKN-007 inhibits TGFB1/SMAD2 and Hedgehog/GLI1 signaling in Huh7 cells. (A) OKN-007 treatment was shown to repress the TGFB1/SMAD2 signaling pathway in Huh7 cells by both SBE reporter luciferase activity assay and immunoblotting for phospho-SMAD2. (B) OKN-007 treatment was shown to suppress the Hh/GLI1 signaling pathway in Huh7 cells by both a GLI reporter luciferase activity assay and immunoblotting for GLI1 protein.</div></div>